Hydroxychloroquine's false hope: How an obscure drug became a coronavirus cure

April 13, 2020

Claims about hydroxychloroquine and chloroquine have taken hold of the global consciousness. Online conversations, media articles and politicians’ statements quickly - and incorrectly - labeled it as a ‘cure’ for covid-19, the disease caused by the novel coronavirus.

Spotlight

Tillotts Pharma AG

Tillotts Pharma AG, part of the Zeria Group, is a fast-growing specialty pharma company with 200 employees in Switzerland and abroad. Tillotts is dedicated to the development, in/out-licensing and commercialization of innovative pharmaceutical products, medical devices and diagnostics, all in the field of gastroenterology.

OTHER VIDEOS

Welcome to the Azelis Pharma lab in Paris, France!

video | January 30, 2023

As a leading global innovation service provider in the specialty chemicals and food ingredients industry, we are committed to creating value for principals and customers whilst providing a great work environment and career opportunities....

Watch Now

Daikyo Crystal Zenith® Insert Needle Syringe

video | January 27, 2023

The Daikyo Crystal Zenith® Insert Needle Syringe system was designed to maintain purity, integrity and efficacy of premium biopharmaceutical therapies....

Watch Now

Little Green Pharma continues to expand making significant strides

video | January 31, 2023

Leading Australian medicinal cannabis exporter, Little Green Pharma continues to expand making significant strides in lucrative global markets...

Watch Now

Teva Expands Partnership to Bring Critical Medicines to Children Living with Cancer

video | January 26, 2023

Teva believes medicine should always be accessible, and we work to help make this a reality. We're working with Global HOPE (Hematology Oncology Pediatric Excellence), a non-profit...

Watch Now

Spotlight

Tillotts Pharma AG

Tillotts Pharma AG, part of the Zeria Group, is a fast-growing specialty pharma company with 200 employees in Switzerland and abroad. Tillotts is dedicated to the development, in/out-licensing and commercialization of innovative pharmaceutical products, medical devices and diagnostics, all in the field of gastroenterology.

Events